KBI Biopharma is a cutting-edge biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that is dedicated to accelerating the advancement of groundbreaking discoveries into transformative biological products. With a strong commitment to expanding global access to vital medicines for patients in need, KBI Biopharma offers a wide range of products and services. Their offerings include Mammalian Cell Line Development, Process Development, Analytical Development, Formulation Development, Characterization, Clinical Manufacturing, and Commercial Manufacturing.

They also specialize in Microbial Cell Line Development, Cell Therapy, and Clinical Support. KBI Biopharma is recognized as a leader in the industry, with their SUREtechnology Platform™, SURE CHO-M Cell Line™, SUREmAb™, and PUREplatform™ technologies. Their team, spread across multiple locations in the US and Europe, is committed to maintaining high standards, nurturing a culture of trust and respect, and fostering learning and growth.

Join KBI Biopharma's dedicated team and experience their world-class analytical capabilities that enable efficient process development and cGMP manufacturing services for mammalian, microbial, and cell therapy programs